GlassScriptPhysician profile
Edward M Farhangi
NPI 1255310751
$1,026.28
in general payments reported to CMS, 2019-2025
15 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.56 · 2020: $27.37 · 2021: $226 · 2022: $53.34 · 2023: $224 · 2024: $235 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $168.86 | 2023-2024 | Optune |
| Icotec Medical INC. | $155.84 | 2021 | |
| Servier Pharmaceuticals LLC | $133.17 | 2025 | |
| Teleflex LLC | $125.00 | 2024-2025 | Barrigel |
| Gt Medical Technologies, INC | $82.95 | 2022-2024 | Gammatile, Gammatile |
| Novartis Pharmaceuticals Corporation | $58.83 | 2024-2025 | |
| Reflexion Medical, INC. | $54.57 | 2021 | |
| Telix Pharmaceuticals | $46.07 | 2024-2025 | Illuccix |
| Boston Scientific Corporation | $42.79 | 2024 | Rezum Generator |
| Siemens Medical Solutions USA, INC. | $35.25 | 2023 | Edge |
| Myriad Genetic Laboratories, INC. | $32.48 | 2022 | |
| Elekta, INC. | $30.61 | 2019-2021 | |
| Sirtex Medical INC | $27.37 | 2020 | |
| Mevion_medical_systems_inc | $16.37 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Farhangi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.